RecallRadar

FDA Drug recall D-1036-2014

Heparin Sodium 2000 USP Heparin Units per 1000 mL (2 USP Heparin Units/mL) in 0.9% Sodium Chloride Injection, Rx only

On 2014-02-05 the FDA classified a Class II recall of Heparin Sodium 2000 USP Heparin Units per 1000 mL (2 USP Heparin Units/mL) in 0.9% Sodium Chloride Injection, Rx only by Hospira, citing lack of Assurance of Sterility; potential leakage from administrative port.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1036-2014
ClassificationClass II
Statusterminated
Initiated2014-01-09
Published2014-02-05
Last updated2026-09-13 11:51 UTC
CompanyHospira
DistributionUS

Product

Heparin Sodium 2000 USP Heparin Units per 1000 mL (2 USP Heparin Units/mL) in 0.9% Sodium Chloride Injection, Rx only. Hospira, Lake Forest, IL 60045. NDC 0409-7620-59.

Reason

Lack of Assurance of Sterility; potential leakage from administrative port.

Identifiers

ndc0409-7620-13
ndc0409-7620-03
ndc0409-7620-49
ndc0409-7620-59
ndc0409-1005-01
ndc0409-1005-20
ndc0409-2222-01
ndc0409-2222-12
code_infoLot #: 26-125-JT, Exp: 8/14

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1036-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.